Assessment of Attention in Vasopressin-Deficient Brattleboro Rats Using a Five-Choice Serial Reaction Time Task by Berquist, Michael D., II
Northern Michigan University
NMU Commons
All NMU Master's Theses Student Works
2013
Assessment of Attention in Vasopressin-Deficient
Brattleboro Rats Using a Five-Choice Serial
Reaction Time Task
Michael D. Berquist II
Northern Michigan University
Follow this and additional works at: https://commons.nmu.edu/theses
This Open Access is brought to you for free and open access by the Student Works at NMU Commons. It has been accepted for inclusion in All NMU
Master's Theses by an authorized administrator of NMU Commons. For more information, please contact kmcdonou@nmu.edu,bsarjean@nmu.edu.
Recommended Citation
Berquist, Michael D. II, "Assessment of Attention in Vasopressin-Deficient Brattleboro Rats Using a Five-Choice Serial Reaction Time







ASSESSMENT OF ATTENTION IN VASOPRESSIN-DEFICIENT 





















Submitted to  
Northern Michigan University 
In partial fulfillment of the requirements  
For the degree of  
 
 
MASTER OF SCIENCE 
 
 















ASSESSMENT OF ATTENTION IN VASOPRESSIN-DEFICIENT 




Michael D. Berquist II 
 
Vasopressin is a neuropeptide that may influence behavioral and cognitive 
processes. The Brattleboro rat is a mutant variation of the Long Evans strain that 
exhibits no circulating vasopressin, resulting in a physiological state analogous to 
diabetes insipidus. Behaviorally, Brattleboro rats exhibit diminished fear conditioning 
and impairments in memory retention and sensory gating. The present study sought to 
further evaluate the cognitive profile of rats with vasopressin deficiency by studying 
attention in male and female Brattleboro rats, Long Evans rats, and heterozygous rats 
using a five-choice serial reaction time task. Sessions to meet criteria were 
significantly greater in the Brattleboro rats than Long Evans and heterozygotic rats; 
and, males required significantly more sessions than Long Evans and heterozygotic 
rats. Female Brattleboro rats displayed significantly poorer attention accuracy 
compared to Long Evans and heterozygotic rats. Premature responses were 
significantly greater in Brattleboro rats than Long Evans and heterozygotic rats. 
Taken together, the present findings add to previous literature suggesting that 
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History of Vasopressin 
In 1895, medical doctor George Oliver and physiologist Sir Edward Albert 
Sharpey-Schäfer discovered that the administration of pituitary gland extracts would 
produce hypertension in animal subjects. Shortly following this observation, Howell 
(1898) concluded that the factor which exerted the pressor effects resided solely within 
the posterior lobe of the pituitary gland. Moreover, it was not until the mid-20
th
 century 
that the two compounds of the posterior pituitary were identified as oxytocin and 
vasopressin, along with their individual roles in peripheral, physiological processes. 
Much of this work is credited to Du Vigneaud and his colleagues whom investigated the 
synthesis and characterization of these physiologically-active substances (e.g., Du 
Vigneaud, 1954-1955; Turner, Pierce, & Du Vigneaud, 1951; Katsoyannis & Du 
Vigneaud, 1958). Due in part to these series of experiments, Du Vigneaud received the 
Nobel Prize in chemistry in 1955. Since this seminal work by Du Vigneaud and his 
colleagues, investigations into vasopressin effects have expanded from peripheral 
functions towards central nervous system mediated effects— including cognitive and 
behavioral domains. The present work focuses on the cognitive effects of vasopressin and 
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Arginine vasopressin (VP) is a neuropeptide/neurohormone consisting of nine 
amino acids (CyS.-Tyr.Phe.Glu-NH2.Asp-NH2.CyS-Pro.Arg.Gly-NH2), which form into 
a ring due to a disulfide bridge located between the two cysteine residues (e.g., 
Katsoyannis & Du Vigneaud, 1958; also see section in Caldwell, Lee, Macbeth, & Young 
III, 2008 for review of VP structure). The VP gene is structurally-similar to the oxytocin 
gene, but is oriented in the opposite transcriptional direction (Mohr, Schmitz, & Richter, 
1988), and thus possesses biologically-distinct actions. Furthermore, the physiological 
activities of VP are centered around different target sites within the body; in this 
document, these sites will be referred to as “peripheral” (or outside of the central nervous 
system) or “central” (or inside the central nervous system). The present introduction will 
focus mainly on the contribution of VP in central processes.  
VP is primarily synthesized in the magnocelluar cells of the hypothalamic 
paraventricular (PVN) and supraoptic nuclei (SON) (Buijs, Swaab, Dogterom, & van 
Leeuwen, 1978; Hou-Yu, Lamme, Zimmerman, & Silverman, 1986), and also within the 
parvocellular cells of the aforesaid PVN (e.g., de Souza & Franci, 2010), and the 
suprachiasmatic nucleus (SCN) (Sofroniew & Weindl, 1980; Buijs, van Eden, 
Goncharuk, & Kalsbeek, 2003).  Large axons of the VP cells within the PVN and SON 
project to the posterior pituitary (e.g., see Brownstein, Russell, & Gainer, 1980) — where 
VP, along with its carrier protein, (denoted neurophysin) (see Zimmerman & Robinson 




response to various physiological stimuli. The two most common peripheral actions of 
VP are: (1) to increase the reabsorption of water (hence VP is also called the “antidiuretic 
hormone”) in the kidneys in response to osmotic stress (e.g., increased osmolality) (e.g., 
Dunn, Brennan, Nelson, & Robertson, 1973), and/or (2) VP can induce vasoconstriction 
in blood vessels in response to alterations in hemodynamics (e.g., hemorrhage of blood 
vessel) (e.g., Pittman, Lawrence, & McLean, 1982).  
Receptors 
Currently, three major receptor types of VP have been identified: arginine-
vasopressin receptor 1a (Avpr1a or V1a), Avpr1b (V1b), and Avpr2 (V2); and all three 
receptor isoforms are shown to be g-protein coupled (see Michell, Kirk, & Billah, 1979; 
and Jard, Barberis, Audigier, & Tribollet, 1987 for review).  Much progress has been 
made in exploring the properties of these receptor isoforms and in assessing the 
functional relevance of VP at these binding sites (e.g., see Barberis, Mouillac, & 
Durroux, 1998 for review). For example, studies have demonstrated that the V2 receptor 
isoform is responsible for mediating the antidiuretic properties in the kidneys (e.g., see 
Jard, Barberis, Audigier, & Tribollet, 1987 for review). Additionally, high-dose 
administration of VP to neonatal rats has been shown to disrupt adult kidney function 
(Handelmann, Russell, Gainer, Zerbe, & Bayorh, 1983); indicating the important role of 
VP in kidney diseases and normal physiological function. Further, following V2 receptor 
activation, the associated intracellular transduction cascade has been shown to involve 
coupling with adenylate cyclase (e.g., see Jard, 1983 for review). Identifying the 




important information not only about the immediate physiological effects following 
receptor stimulation, but also about possible long-term, modulatory effects of various 
biochemical agents such as VP.  
Different from the transduction cascade pathways associated with kidney V2 
receptors, V1 receptors located in vasculature (i.e., receptors coupled to smooth muscles) 
(e.g., Nabika, Velletri, Lovenberg, & Beaven, 1985) and in the hepatocytes of the liver 
(e.g., Cantau, Keppens, De Wulf, & Jard, 1980; Michell, Kirk, & Billah, 1979),  have 
been shown to be coupled with phospholipase; which initiates the phosphoinositol 
pathway(s) to elevate intracellular Ca
2+
 concentrations (e.g., see Jard, Barberis, Audigier, 
& Tribollet, 1987), among other intracellular processes. Furthermore, previous literature 
suggests that the VP receptors in the brain predominantly consist of the V1 isoform (e.g., 
Kiraly, et al., 1986; Shewey & Dorsa, 1988).  Thus, it is likely that central V1 receptors, 
rather than V2 receptors, mediate the putative behavior and cognitive effects of VP. 
Binding Sites and Distribution 
In addition to the intracellular properties associated with the VP receptors, 
numerous receptor binding sites have been identified in the brain. Many of these sites are 
observed to exist in areas throughout the central nervous system, (away from the majority 
of VP cell bodies found within the PVN, SON, and SCN), and within numerous 
accessory nuclei. For example, Caffe and van Leeuwen (1983) found binding sites to 
exist in the dorsomedial hypothalamus, the medial amygdala, and the locus coeruleus—
structures which are involved in a number of behavioral domains. Shortly following this 




within such structures as the septum, central amygdala, dentate gyrus, olfactory nucleus, 
and the nucleus tractus solitarii. With these findings taken together, VP has thus been 
implicated in various domains affiliated with the aforementioned regions. Further, given 
the large number of VP binding sites found within these accessory areas, other research 
during this time began to identify numerous axonal projections of VP; which may offer 
important information on the functional relevance of these associated binding sites. 
Early microscopy work identified a number of VP projections within the brain—
some of which terminate at the binding sites noted previously. For example, Buijs (1980) 
identified distinct vasopressinergic (VPergic) projections which extended from the 
magnocellular nuclei of the PVN and/or SON, and/or from the parvocellular nuclei of the 
SCN. Specifically, magnocellular VPergic projections were found to extend to the 
amygdala, hippocampus, and spinal cord; and, parvocellular projections to the organum 
vasculosum of the lamina terminalis, the lateral septum, and the lateral habenular nucleus 
(Buijs, 1980).  Additionally, during this time, Sofroniew (1980) using a 
immunoperoxidase method, found magnocellular projections (i.e., PVN) to extend 
towards the substantia nigra, the nucleus tractus solitarii, the nucleus commissuralis, and 
to the spinal cord; and, parvocellular projections (i.e., SCN) to extend towards the 
septum, thalamus, medial amygdala, ventral hippocampus, and a number of other regions 
(for review on VPergic projections, see section in De Wied, Diamant, & Fodor, 1993). 
Therefore, given the large number of VPergic projections found within the brain, it is 
thus possible that the neuropeptide may also serve central, neurotransmitter-like roles 







As mentioned previously, there are numerous projections of VP axons found 
within the brain—many of which been shown to stem from the SCN and project to a host 
of other target tissues (e.g., Buijs, 1980; Sofroniew, 1980). It has been known for some 
time that the SCN, or the “master clock” of an organism, is largely responsible for the 
circadian rhythmicity of a multitude of biochemical agents. The SCN performs this 
rhythmic control through acting upon various cellular compartments located throughout 
the body— such as along specific gene fragments within a cell’s nucleus. Moreover, VP 
release has been shown to be entrained to such circadian rhythmicity with peak release 
occurring during the subjective day phase—although VP release may vary between 
species (Reppert Schwartz, Artman, & Fisher, 1983). Given this known relationship 
between the SCN and release of VP, physiological actions associated with its rhythmic 
release have also been found (e.g., see Buijs, van Eden, Goncharuk, & Kalsbeek, 2003, 
for review on the SCN and associated biochemical components) . For example, the 
circadian release of VP has been shown to exert a modulatory effect on the secretion of 
corticotrophin releasing factor (CRF) and adrenocorticotropic hormone (ACTH) (e.g., 
Raymond, Leung, Veilleux, & Labrie, 1985)—two compounds which are in part 
responsible for the excessive cortisol release during periods of chronic stress (e.g., 
Aguilera, 1994; Volpi, Rabadan-Diehl, & Aguilera, 2006). Furthermore, research has 
suggested that VP may function to amplify the excitatory effect produced by the SCN 




between VP and the SCN has stimulated research which further explores the utilization of 
the neuropeptide within circadian domains.  
Social Behaviors 
There are several areas of social behavior that may be modulated by the effects of 
VP. One such research area that has received much attention has been aggression. 
Aggressive behavior, for instance, has been shown to increase following microinjections 
of VP into the anterior hypothalamus of Golden hamsters (Ferris et al., 1997). Moreover, 
a direct relationship has been suggested to exist between the V1a receptor isoform and 
aggression as studied in Syrian hamsters— with a higher V1a receptor distribution in the 
anterior hypothalamus equated to increased observed aggression (Albers, Dean, Karom, 
Smith, & Huhman, 2006). Accompanying the V1a receptor studies which associate the 
receptor isoform with aggression, additional research has shown that mice lacking the 
V1b isoform, display reduced aggression, and alterations in social recognition as well 
(Wersinger, Ginns, O’Carroll, Lolait, & Young III, 2002). Based on these studies, VP 
may serve a modulatory role in aggressive behaviors and further research is thus 
necessary to elucidate the biochemical actions VP places within specific areas of the 
brain affecting such behavioral responses. 
Other aspects of social behavior, such as pair-bonding and social recognition, 
have been examined as well. Perhaps among the most robust observations involving VP 
and social behaviors, has been through the examination of VP receptor distributions in 
the ventral pallidum that exist between different species of voles (see, Donaldson, & 




between the high-VP receptor distribution located within the ventral pallidum of the 
prairie vole—which results in a monogamous behavioral phenotype— and, with the low-
VP receptor distribution within the ventral pallidum of the nonmonagamous meadow 
vole (Donaldson & Young, 2008). Furthermore, by using a viral-vector method of 
transferring genes, previous studies have found that if the VP gene is taken from the 
monogamous prairie vole, and transferred to the nonmonagamous meadow vole, the 
meadow vole will then adopt the social behavior of the prairie vole (Donaldson & Young, 
2008). Therefore, it seems that that the distribution levels of VP are largely responsible 
for inducing a specific behavioral phenotype within the vole species.  
In addition to the aforementioned vole studies, the importance of VP and social 
behaviors has been suggested to be more relevant to males than females— as females do 
not appear to rely on VP for social recognition as much as males (Bluthe & Dantzer, 
1990; Bielsky, Hu, & Young, 2005). Despite this robust observation, research using 
rodents has found relationships between VP neurotransmission and social behaviors. For 
instance, Engelmann, Ludwig, and Landgraf (1994), using a microdialysis procedure, 
found that following stimulation to the SON,  a significant correlation existed between 
endogenous VP release in the SON and septum, and  increased social memory 
(recognition) performance  in male rats. Additionally, this improvement could be 
partially blocked by a V1 receptor antagonist (Engelmann, Ludwig, & Landgraf, 1994).   
This association found between VP release and social memory would be further 
delineated with successive research using transgenic mice models.  Current research has 




knockout mice compared to wildtype controls (Bielsky, Hu, Szegda, Westphal, & Young, 
2004; Egashira et al., 2007); and mild impairments in social recognition to exist in V1b 
knockout mice (Wersinger, Ginns, O’Carroll, Lolait, & Young III, 2002). Furthermore, 
by re-expressing the V1a gene in the lateral septum of V1a knockout mice, deficits in 
social recognition became completely restored (Bielsky, Hu, Ren, Terwilliger, & Young, 
2005). These findings suggest that the V1a receptor in the lateral septum is necessary for 
normal social recognition function (at least in male rodents; see above). Taken together, 
these data suggest the relevance of VP in modulating social behaviors.  
Stress, Depression, and Anxiety 
VP has been previously demonstrated to have fibers projecting to the zona externa 
of the median eminence (e.g., Antunes, Carmel, & Zimmerman, 1977), and thus to the 
anterior pituitary (via a blood portal system). Given the terminating sites of these VPergic 
projections to the median eminence, it has been postulated that VP may affect the 
pituitary-adrenal-axis (e.g., Antunes, Carmel, & Zimmerman, 1977).  It was later found 
that stress-responsive components, such as CRF (also referred to as “corticotropic 
hormone”), and ACTH, are physiologically-involved with the hypothalamic-pituitary-
axis (HPA) (referring to the anterior pituitary) (e.g., Rivier & Vale, 1983; Aguilera, 1994; 
Volpi, Rabadan-Diehl, & Aguilera, 2006). Moreover, as mentioned above, VP has been 
shown to exert a modulatory role on the release of HPA-affiliated stress-response factors, 
such as CRF and ACTH (e.g., Rivier & Vale, 1983; Aguilera, 1994); and additionally, 
cell bodies of AVP and CRF have been found to co-localize in the external region of the 




support a physiological relationship to exist directly between VP and the factors (e.g., 
CRF, ACTH, cortisol, etc.) included in mediating the effects of chronic stress. 
Furthermore, behavioral studies have provided additional evidence supporting the impact 
of VP in the stress response.  For example, rats put into a 10-minute forced swim session 
were shown to have elevated levels of VP release in both the SON and PVN (Wotjak et 
al., 1998; and for review on VP and stress, see section in Caldwell, Lee, Macbeth, & 
Young III, 2008).  
Accompanying the direct association between VP, CRF, ACTH, and the anterior 
pituitary, physiological interactions have been found between the V1b receptor isoform 
and the adrenal glucocorticoids. For example, recent evidence shows that V1b receptor 
up-regulation or down-regulation will occur depending upon circulating levels of 
glucocorticoids (Aguilera & Rabadan-Diehl, 2000). The release of glucocorticoids is 
directly proportionate to signals coming from the HPA, and once in circulation and thus 
reaching the brain, glucocorticoids exert numerous effects on functional 
neurochemistry—many effects which are strongly associated to stress, anxiety, and 
depression (for review, see Nestler et al., 2002). Moreover, elevated levels of VP have 
been found in the plasma of depressed patients compared to healthy controls (van Londen 
et al., 1997); and treatments for depression, such as the selective-serotonin reuptake 
inhibitor Fluoxetine, has been shown to increase VP afferent development in select brain 
regions (Ricci & Melloni Jr., 2012). These findings taken together suggest that VP shares 
a relationship with the mechanisms associated with depression, and thus may serve a 




In addition to the role of VP in the induction of stress and depression, the V1a 
receptor has received support for influencing anxiety-related measures as well. For 
example, V1a receptor knockout mice have been shown to exhibit reduced anxiety-like 
behavior in an elevated plus maze (Egashira et al., 2007); and, pharmacologically, V1 
receptor antisense administration has been shown to reduce anxiety-related behavior in 
rats (Landgraf et al., 1995). Moreover, given the extensive literature supporting the role 
of VP in stress, depression, anxiety, and the structures affiliated with these ailments— 
which also contain VPergic projections, such as the amygdala (e.g., Willcox, Poulin, 
Veale & Pittman, 1992; Dorsa, Petracca, Baskin, & Cornett, 1984), and the hippocampus 
(Zhang & Hernandez, 2013)— VP has thus received much attention which attempts to 
delineate its functional relevance in these pathologies (for review see Scott & Dinan, 
1998; De Wied & Sigling, 2002; Neumann & Landgraf, 2012). 
Brattleboro Rats 
History 
The Brattleboro rat was discovered as a useful model for studying possible 
relationships between VP and associated behaviors. The strain was identified during the 
1960’s in Brattleboro, Vermont. Dr. Henry Schroeder and his associate Mr. Tim Vinton 
noticed that some of the rat pups in their breeding colony were drinking excessive 
amounts of water, and with the administration of VP, this behavior could be corrected 
(Valtin, 1982; Mohring et al., 1978). After isolating these rats and reporting the behavior 
to several enthused colleagues, the Brattleboro rats as the “water-consumers” came to be 




experimentally (Valtin, 1982). Moreover, the Brattleboro rats displayed polydipsic 
behavior (excessive water consumption) and polyuria (excessive urination), and therefore 
have been considered to be an animal model of congenital diabetes insipidus.  
Genetics and Characteristics 
It was later determined that the cause of the Brattleboro rats’ excessive water 
consumption was due to a single guanisine residue deletion in the second exon of the 
arginine VP gene (Schmale & Richter, 1984). This deletion results in impaired secretion 
of the neuropeptide, which results in no circulating VP found in the animal (Schmale, 
Ivell, Brendl, Darmer, & Richter, 1984; Majzoub, Carrazana, Shulman, Baker, & 
Emanuel, 1987; Grant, 2000). Further, several alterations have been found in the 
Brattleboro rats in various hormonal factors (for review, see Sokol & Zimmerman, 1982) 
and neurotransmitter concentrations (Dawson, Wallace, King, 1990; Feenstra, 
Snijdewint, Van Galen, & Boer, 1990). Extensions of these alterations into various 
domains will be discussed later in this document.  
In addition to the excessive drinking behavior found in the Brattleboro rats, body 
growth (measured in body weight), tail length and posterior pituitary gland weight were 
also found to be underdeveloped compared to wildtype controls (Arimura, Sawano, 
Redding, & Schally, 1968).  Upon further examination, Arimura, Sawano, Redding, and 
Schally (1968) also found that growth hormone content in the posterior pituitary of 
Brattleboro rats was significantly lower than what was found in controls; however, 
growth-hormone releasing factor (the chief regulatory factor responsible for the synthesis 




compounds beyond growth-hormone releasing factor may be responsible for the impaired 
somatic development observed in the Brattleboro rats (Arimura, Sawano, Redding, & 
Schally, 1968).  
Along with the previously mentioned deficiencies in somatic development and 
concentrations of growth hormone found with the Brattleboro rats, the strain has also 
been shown to have smaller brains (4-9% smaller) compared to heterozygous controls 
(Boer, Van Rheenen-Verberg, & Uylings, 1982). Additionally, diminished proliferative 
growth of the cerebellum and medulla oblongata were also found in both male and female 
Brattleboro rats (Boer, Van Rheenen-Verberg, & Uylings, 1982). Accompanying these 
structural underdevelopments, numerous molecular components were found to be 
reduced as well—specifically, DNA content in the forebrain, cerebellum, and olfactory 
bulbs were found to be lower in Brattleboro rats compared to heterozygotic controls 
(Boer & Patel, 1983). Furthermore, expressed differences in monaminergic agents—
including elevated levels of dopamine, serotonin, noradrenaline/norepinephrine, 
glutamine, and taurine in select brain regions—have been observed to exist in the 
Brattleboro rats versus wildtype controls (Dawson, Wallace, & King, 1990; Feenstra, 
Snijedwint, Galen, & Boer, 1990). These differences may exist due to the putative role of 
VP as a key neuropeptide which interacts with various factors in neurodevelopment (see 
Boer et al., 1980; and Ugrumov, 2002, for review on VP and neurodevelopment); such as 
modulating the noradrenaline neurotransmission pathways (e.g., Boer, Feenstra, 






One of the first extensions of VP into the domain of mental processing came 
through the work of De Wied and colleagues during the mid-1900’s. For instance, in a 
shuttlebox conditioned avoidance response paradigm—which can be suggested to 
measure contexutal memory (i.e., pairing an environment with a specific stimulus such as 
a shock) — it was found that animals with ablations to the posterior and intermediate 
lobes of the pituitary gland displayed impairments in the maintenance of an avoidance 
response (De Wied, 1965). Moreover, multiple doses and varied administration intervals 
of VP analogues were assessed in rats, and found to augment memory retention in active 
and passive avoidance tasks in a time-dependent manner (Bohus, Ader, & DeWied, 
1972). This preliminary research stimulated the hypothesis that VP may subserve some 
modulatory role in memory processes. 
Also during this time, the Brattleboro rats were becoming a model employed to 
investigate the effects of VP deficiency (see Valtin, 1982). Ostensibly due to the 
emergence and utilization of this mutant rat for research purposes, De Wied and 
colleagues were able to investigate the strain in several animal-memory paradigms. For 
example, it was noted that the Brattleboro strain exhibited deficits in learning, compared 
to heterozygotic rats with partial VP deficiency, using a one-trial step-through passive 
avoidance test (De Wied, Bohus, & van Wimersma Greidanus, 1975). Additionally, 
following administration of desglycinamide-8-lysine, a VP analogue, these deficits were 




The relationship between VP and shuttlebox behavior were expanded upon in 
Bohus, van Wimersma Greidanus, and De Wied (1975) where the Brattleboro rats were 
found to have deficits in acquisition of avoidance, extinction of behavior in pole jumping 
avoidance, and in the retention of passive avoidance response.  In response to these 
findings and the conclusions made therein about the Brattleboro strain, other researchers 
such as Brito, Thomas, Gingold, and Gash (1980), sought to delineate other types of 
memory (e.g., reference-memory) that may be impaired in this strain and suggested that 
the Brattleboro rats exhibit deficits in reference-memory, and perhaps mild impairments 
in working-memory. Additionally, subsequent pharmacologic studies were also providing 
evidence supporting the role of VP in memory as well. For example, Strupp and 
colleagues (1990) noted that the administration of a VP metabolite was shown to improve 
memory retrieval in a rat social interaction, appetitive-motivated paradigm. These studies 
would provide assessments of memory performance in the Brattleboro rats, and further 
support the role of VP within this cognitive domain.  
Conflicting with these findings in the shuttlebox behavior, Brito, Thomas, Gash, 
and Kitchen (1982) were not able to replicate these results; rather, there were no 
differences found between Brattleboro rats and controls in shuttlebox/shock-motivated 
assessments (i.e., approach-avoidance conflict, passive avoidance), in performance in a  
working memory task (alternating T-maze), in visual and olfactory discrimination 
(reference memory), and in a species-specific behavioral response (i.e., burying an 
aversive stimulus as a defensive response (see Pinel & Treit, 1978 for further information 
of this behavior)). Moreover, the researchers concluded that the Brattleboro rats exhibited 




conflict with performance in these cognitive-behavioral tasks (Brito, Thomas, Gash, & 
Kitchen, 1982). This conclusion provides a relevant point to consider when speculating 
about Brattleboro rats’ performance in cognitive-behavioral tasks, and will be considered 
later in this document. In addition, to add further robustness to experiments, researchers 
have incorporated rats with partial VP deficiency as well. For example, Aarde and 
Jentsch (2006) found delay-dependent deficits in choice accuracy in heterozygote rats 
(with partial deficiency in VP) compared to wildtype Long-Evans controls, using a 
delayed-non-to-match position paradigm— a model suggested to measure spatial 
working memory. These memory studies taken together add supporting evidence for a 
central, modulatory role of VP in cognitive domains, though conclusions about how VP 
exerts these effects differentially across paradigms remain unclear.   
As mentioned previously, the Brattleboro rats have been suggested to exhibit 
different emotional profiles than other strains. To test this hypothesis, researchers 
examined the Brattleboro rats using animal measures of emotionality—one such measure 
is the freezing response. For example, one study found attenuated freezing responses in 
Brattleboro rats using a conditioned freezing paradigm (Stoehr, Cheng, & North, 1993).  
As a follow-up to this finding, similar attenuated freezing responses were found in 
normal rats following V1 antagonism administration (Stoehr, Cheng, Serlin, Cramer, & 
North, 1993). Taken together, these studies lend support to the notion that the Brattleboro 
rats display an altered emotional response.  Moreover, these results also suggest that VP 
plays a role the retention of this behavior— as the study using pharmacologic 
manipulation of VP indicated. Further, Colombo, Hansen, Hoffman, and Grant (1992) 




levels of timidity (measured by adaptability in a novel environment) in a t-maze 
paradigm, than what was found in Brito, Thomas, Gash, and Kitchen (1982); suggesting 
that the DI gene itself may not be responsible for the altered timidity found within the 
Brattleboro strain. Clearly, more research is necessary that evaluates the differences 
between the parameters set within these paradigms, and for potential differences in 
Brattleboro rats from different breeders—as rats from different colonies may display 
different behavioral and emotional profiles (e.g., noted in Laycock, Gartside, & 
Chapman, 1983; also see, Herman, Thomas, Laycock, Gartside, & Gash, 1986). 
In addition to the shock-avoidance studies mentioned above,  recent research has 
provided suggestions about the effects of maternal genotype on Brattleboro rats’ stress 
response function and development (e.g., Zelena, Mergl, & Makara, 2009); adding 
further complexity to exploring the emotional profile of the Brattleboro strain. Further, 
Brattleboro rats have been shown to exhibit attenuated depression-like behavior in a 
forced swimming test (Mlynarik, Zelena, Bagdy, Makara, & Jezova, 2007), and 
prolonged elevation of plasma corticosterone and oxytocin levels following a 10-minute 
forced swim stressor (Zelena et al., 2009).  Taken together, these findings suggest that the 
Brattleboro rats exhibit irregularities in stress-response activity; however, further research 
is necessary to delineate the neurophysiological causes of these irregularities, and to what 
impact they may have on performance in cognitive-behavioral tasks. 
Along with previous studies indicating that the Brattleboro display altered stress 
responses compared to controls using a forced-swim stressor (Mlynarik, Zelena, Bagdy, 




(Stoehr, Cheng, & North, 1993; Bohus, van Wimersma Greidanus, & De Wied, 1975; De 
Wied, Bohus, van Wimersma Greidanus, 1975), the strain has been found to exhibit 
alterations in other cognitive domains as well. For example, innate social recognition 
deficits in the Brattleboro strain have also been ameliorated following administration of 
synthetic arginine VP into the septum of the rats, and similar deficits can be induced in 
Long Evans rats following V1 antagonist administration into the same brain region 
(Engelmann & Landgraf, 1994). One other area of cognition examined in the Brattleboro 
strain, has been attention. Recently, the Brattleboro strain has been found to exhibit 
deficits in pre-pulse inhibition (e.g., Feifel & Priebe, 2001)—which is suggested to 
measure a pre-attention process referred to as “sensorimotor gating.” Moreover, this 
finding has also been found in female Brattleboro rats (Feifel, Shilling, & Melendez, 
2010); which, suggests the effects are due to some quality of the Brattleboro strain rather 
than a sexually-dimorphic characteristic. Moreover, the deficits are ameliorated in both 
sexes of the Brattleboro strain following antipsychotic administration (Feifel, Shilling, & 
Melendez, 2010) and novel experimental antipsychotic administration in male rats 
(Feifel, Melendez, Priebe, & Shilling, 2007). The implications of these findings will be 
discussed later in this document. 
As mentioned previously, deficits in sensorimotor gating were observed in the 
Brattleboro rats; which suggest that the absence of VP could potentially modulate aspects 
of attention as well. Moreover, Jentsch, Arguello, and Anzivino (2003) found that 
Brattleboro rats displayed deficits in attentional engagement using a lateralized reaction 
time task. Briefly, this study required animals to correctly respond to visual stimuli via 




initiated via nose poke into a central aperture. Following this response, a visual stimulus 
was presented randomly in one of two apertures located on either side of the central 
aperture. Measures of accuracy, response times, premature responses, omissions, 
incorrect responses, and reinforcement retrieval times were collected (Jentsch, Arguello, 
& Anzivino, 2003). Furthermore, Jentsch (2003) found superior performance in a 
lateralized reaction time task using rats with partial VP-deficiency; which, overall, these 
studies suggest that VPergic tone may exert some effects on attention performance within 
the parameters of the lateralized reaction time task.  Amid these prior studies using the 
lateralized reaction time task, further evaluations assessing the Brattleboro rats, VP, and 
attention must be examined. Therefore, further research is necessary to measure other 
aspects of attention and motivation not assessed in the lateralized reaction time task. 
The Five-Choice Serial Reaction Time Task  
The operant five-choice serial reaction time task (5-CSRTT) has been commonly 
used to assess attention since the 1970’s (for review, see Robbins, 2002). This method of 
assessing attention in animal models is more common than the aforementioned lateralized 
reaction time task and differs from the paradigm in several ways. Briefly, the 5-CSRTT 
requires animals to visually detect a stimulus light presented randomly in one of five 
apertures within a fixed-time period. The animals initiate the task by emitting a response 
on a stimulus (e.g., pressing a lever) within the chamber. This response then results in the 
appearance of the visual stimulus to occur randomly in one of five apertures and within a 
fixed-time period. Subjects must then nose-poke the illuminated hole within a fixed-time 




nose-poke response (omission), a response before the onset of the visual stimulus 
(premature response), or a response into an incorrect aperture following visual stimulus 
presentation (incorrect response), results in a time-out period (e.g., typically a five-
second period where the houselight is extinguished and response on the stimulus that 
typically initiates a trial has no outcome).  
To vary the parameters associated with the 5-CSRTT, higher attentional demands 
can be placed on the subjects by altering the visual stimulus duration (e.g., changing the 
stimulus duration from 1.0 sec to 0.1 sec), and through varying the inter-trial interval 
(ITI) (i.e., instead of the visual stimulus appearing 5.0 seconds following head entry, have 
it randomized to appear 1.0, 5.0, and 10.0 seconds following entry). Additionally, 
distractors, such as bursts of white noise, can also be incorporated into the 5-CSRTT 
paradigm to add further attentional demands on the subjects.  
The 5-CSRTT is regarded as an assessment of attention accuracy— including 
spatial attention, attention shifting, and inhibitory control— as well as other variables 
such as motivation, impulsivity, compulsivity, and cognitive flexibility (e.g., Robbins, 
2002; Chudasama & Robbins, 2004;Amitai & Markou, 2010).  These characteristics 
make the 5-CSRTT a robust animal model for evaluating multiple facets of behavior and 
mental processing. Moreover, although similar to the lateralized reaction time task in 
some ways, the 5-CSRTT may add further attentional engagement due to 1) an increase 
in task difficulty and 2) requiring the animal to shift attention from a stimulus that 
initiates a trial to a second stimulus located elsewhere in the experimental chamber (See 




measurements of attention not addressed by the lateralized reaction time task, and may 









Vasopressin has been implicated within various behavioral and cognitive 
domains, such as memory, social behaviors, and mental disorders, and is thus a relevant 
compound to consider for experimental examination. One of the challenges associated 
with experimental analyses is identifying a potential animal model which has high 
construct validity. The Brattleboro rat strain is uniquely relevant to addressing this 
challenge by possessing a genetic condition which completely impairs the animal’s 
ability to synthesize vasopressin. Moreover, recent evidence has suggested that the 
Brattleboro rats exhibited deficits in such areas as memory (e.g., Stoehr, Cheng, & North, 
1993), attentional engagement (Jentsch, Arguello, & Anzivino, 2003), sensorimotor 
gating (e.g., Feifel, Shilling, & Melendez, 2010), and social discrimination (Feifel et al., 
2009). These findings provide further support for incorporating the Brattleboro strain in 
models that may address deficits associated with human mental disorders. 
 
To date, no previous study has evaluated the Brattleboro rats in the five-choice 
serial reaction time task—a well-validated assessment of attention. Additionally, 
experimental studies are lacking that include female Brattleboro rats into their analyses, 
so much of the knowledge about potential sex differences within this strain are largely 
unknown. Therefore, the present study sought to assess attention performance in 
vasopressin-deficient rats by studying homozygous Brattleboro rats, heterozygous 




Long Evans rats using a 5-CSRTT paradigm. Experiments also included both male and 
female rats to evaluate potential sexually-dimorphic effects of vasopressin deficiency. 
These findings expand upon the neurocognitive profile of the Brattleboro rats and suggest 
that levels of circulating vasopressin may influence aspects of attention, depending on 
sex. The goal of this study was to evaluate both male and female Brattleboro rats in a 
common animal model of attention, the five-choice serial reaction time task. This 
research further supports the utilization of the Brattleboro rat within cognitive and 















Male and female Brattleboro (BRAT) rats (N=10 and N=8, respectively) and 
heterozygotes (HZ) rats (N=10 and N=10) were obtained from a breeding colony at 
University of California, San Diego (San Diego, CA, USA), while male and female Long 
Evans rats (N=10 and N=10) were obtained from Charles River Laboratories (Portage, 
MI,  USA).  Animals were housed in a temperature and humidity-controlled vivarium 
kept on a 12 hour light-dark cycle with free access to water in their home cages. Food 
was restricted to a single daily feeding in order to maintain 85% of free-feed body 
weights.  Rats were group housed within strain and sex, with the exception of male 
Brattleboro rats, which had to be separated due to aggressive behavior. Following 
training sessions, rats were individually housed for 30 min to provide a feeding period.  
Supplemental food pellets were subsequently provided in their homecages upon returning 
to group housing.  All procedures were consistent with the Guide for the Care and Use of 
Laboratory Animals (2011) and were approved by the Institutional Animal Care and Use 
Committee at Northern Michigan University. Experimental sessions were conducted five 
days per week. 
Apparatus 
These procedures used eight rat operant chambers contained in sound-attenuating 
cabinets equipped with fans for ventilation and masking noise (Med-Associates, St. 




on the center of one wall, directly below the food pellet dispenser that delivered 45 mg 
dustless food pellets (BioServ, Frenchtown, NJ, USA). This wall also contained a 
houselight and receptacle for a 100ml water bottle, both located near the ceiling. The 
opposite wall contained five equally-spaced apertures equipped with stimulus lights and 
photo beam sensors.  All experimental events and data collection was conducted using 
Med-PC version IV software (Med-Associates). 
Training procedures 
Prior to 5-CSRTT training, a 45 min acclimation session was conducted by 
placing rats in the experimental chambers with only the house light activated and the 
food-pellet dispenser set to fixed time 60 sec schedule. This session was included to 
habituate the animals to the experimental chambers and to the location and the sound of 
the food magazine. All animals moved onto training following this habituation session. 
Training for the 5-CSRTT was conducted in five phases, and all training sessions 
ended after 100 trials or 30 min, whichever came first.  During the first phase, all 
stimulus lights were activated and a nose-poke into any of the apertures resulted in the 
delivery of a food-pellet reinforcer. A nose-poke also deactivated all stimulus lights for a 
5 sec period.  First-phase training sessions were 30 min in length and the training criteria 
consisted of a rat evoking at least 10 nose-pokes for 1 session. This first phase aimed to 
train the animals to establish the nose-poke contingency.  
 During the second phase of training, rats were required to press the center lever 




to the deactivation of the stimulus lights and the delivery of a food pellet. Rats moved on 
to the third phase of training after achieving at least 10 food pellets within a single 
session.  
Phase three training procedures were similar to phase two except that a lever press 
led to the activation of only one stimulus light, which was selected randomly 5 sec later.  
Only a nose-poke into signaled aperture led to the delivery of a food-pellet, whereas no 
experimental event occurred after a nose-poke into a non-signaled aperture. However, 
failing to emit a nose-poke into the lit aperture within 5 sec (an “omission”) led to 
deactivating the stimulus light and the houselight for a 5 sec period.  After the timeout 
period ended, another lever press was necessary to activate a stimulus light.  The goal of 
establishing this contingency was to train the rats of a temporal consequence following 
the absence of a response. In order to proceed to phase four, rats were required to omit no 
more than 10 percent of total trials for 2 out of 3 consecutive sessions.  
Phase four was identical to phase 3 except that a nose-poke occurring during the 5 
sec after the lever press, but before the activation of a stimulus light (a “premature 
response”), led to a timeout.  This training phase introduced the animals to another 
condition (in addition to an omission) that would result in a timeout period. The goal of 
this phase was to minimize both premature and omission values during a training session. 
As such, the criterion for proceeding to the final phase of 5-CSRTT training was 2 out of 
3 consecutive trials where omissions and premature values were no more than 10 percent 




The final phase of 5-CSRTT training was identical to the fourth phase of training 
except that stimulus was shortened to 0.5 sec and nose-pokes occurring in the signaled 
aperture within 5 sec led to a food-pellet delivery.  Moreover, incorrect responses led to a 
timeout. If the animal made a nosepoke in the correct aperture, a food pellet was 
immediately delivered.  Training continued until correct choice accuracy had stabilized; 
which was defined as no more than 10% variation in correct choice accuracy with 
omitting no more than 20% total trials initiated for 6 out of 8 consecutive sessions. Once 
choice accuracy had stabilized for an individual rat, that rat was considered to have 
completed the 5-CSRTT training. (See Appendix B for box diagram detailing the 
procedure of the final 5-CSRTT training phase).  
Bodyweight and water intake 
 Immediately following completion of 5-CSRTT training, all rats were free-fed for 
bodyweight and water consumption analysis. In addition to the homecage water 
consumption assessment, the free-fed rats were put into the experimental chambers 
supplied with a water bottle to assess water consumption for a 60 min period. The doors 
on the experimental chambers were left open during this session. Two measures were 
recorded during this 60-minute session: 1) the amount of water consumed from the 100ml 







   
The following dependent variables were measured for 5-CSRTT performance:  
percent accuracy, trial omissions, and premature responses.  Data were reported as means 
(+/- the standard error of the mean [SEM]).  Percent accuracy was calculated by dividing 
the number of correct responses by the sum of correct and incorrect responses, and then 
multiplying this value by 100.   Each rat’s stable percent accuracy value was reported as 
the mean percent accuracy across the 8 sessions where training criteria were met for the 
final phase of 5-CSRTT training.  Means for premature responses and omissions were 
calculated in the same manner. All 5-CSRTT dependent variables were analyzed using a 
one-way between groups analysis of variance (ANOVA). Statistically significant 
differences were further assessed using the Unprotected Fisher’s Least Significant 
Difference (LSD) multiple comparisons test.  A chi-square analysis was conducted to 
assess differences in the number of rats meeting the final-phase training criteria between 
strains.  A one-way ANOVA was conducted to assess differences in free-feed 
bodyweights, 24 hour homecage water consumption, or experimental dependent variables 
between strains in male or female rats during the 60-minute session. Again, statistically 
significant differences were further assessed using the Unprotected Fisher’s LSD multiple 
comparisons test. 
Given that sample sizes were reduced due to some rats failing to meet the training 
criteria, which subsequently reduced power, one-way between groups ANOVAs were 
also conducted in order to provide an assessment of strains between samples containing 




using Unprotected Fisher’s LSD comparisons tests. All analyses were conducted using 








Sessions to training criteria 
Rats were determined to have failed to learn the task if they exceeded the number 
of sessions to meet a phase by over two standard deviations, compared to the mean 
number of sessions met by the other rats of the same strain and sex. In addition, one LE 
male rat died prior to the final 5-CSRTT phase.  The number of rats completing the final 
5CSRTT training criteria consisted of the following: male Long Evans (LE) (6 out of the 
original 10), female LE (9/10); male heterozygotes (HZ) (9/10), female HZ (6/10); and 
male Brattleboro rats (BRAT) (6/10), female BRAT (5/8).  As mentioned previously, 
given the relatively low samples sizes reached for many of the groups, a one-way 
between groups ANOVA was conducted to assess differences between strains in groups 
containing both male and female rats. 
Figure 1 presents the number of male rats that completed all training. No 
statistically-significant differences were found in the number of males rats per strain that 
completed the training χ
2
(2, N=29) = 2.468, p > 0.05. 
Figure 2 presents the number of female rats that completed all training. No 
statistically-significant differences were found in the number of female rats per strain that 
completed the training χ
 2




Figure 3 presents the number of male and female rats that completed all training. 
No statistically-significant differences were found in the number of male and female rats 
per strain that completed training χ
 2






Figure 1 shows the number of animals as a function of status (pass or fail) 
and strain (LE, HZ, or BRAT) in the male rats completing the 5-CSRTT 
training. 
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Figure 2 shows the number of animals as a function of status (pass or fail) 
and strain (LE, HZ, or BRAT) in the female rats completing the 5-CSRTT 
training.  
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Figure 3 shows the number of animals as a function of status (pass or fail) 
 and strain (LE, HZ, or BRAT) in the male and female rats completing the 
 5-CSRTT training.  
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Figure 4 presents the mean number of sessions to meet criteria for the male rats 
Statistically significant effects were found in males, F(2,18) = 4.022, p < 0.05, which 
were due to BRAT rats requiring significantly more sessions to meet the training criteria 
than LE and HZ rats. No statistically significant effects were found between LE and HZ 
rats.  
Figure 5 presents the mean number of sessions to meet criteria for the female rats. 
No statistically-significant differences were found in female rats F(2, 17) = 0.3587, p > 
0.05.   
Figure 6 presents the mean number of sessions to meet criteria for the male and 
female rats. Statistically-significant differences in the number of sessions to meet the 
training criteria were observed between strains for male and female rats F(2,38) = 3.339, 
p < 0.05, which were due to BRAT rats requiring significantly more sessions to meet the 
training criteria than LE and HZ rats.  No statistically significant effects were found 






Figure 4 shows the mean number of sessions as a function of strain 
  (LE, HZ, or BRAT) in the male rats, *p < 0.05 versus LE,  +p < 
 0.05 versus HZ. 
  
M a le





















Figure 5 shows the mean number of sessions as a function of strain 
  (LE, HZ, or BRAT) in the female rats. 
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Figure 6 shows the mean number of sessions as a function of strain 
  (LE, HZ, or BRAT) in the male and female rats, *p < 0.05  versus 






Figure 7 presents percent accuracy data during the sessions where training criteria 
were met for male rats. Percent accuracy for the male rats did not differ significantly 
F(2,18) = 0.0629, p > 0.05 
Figure 8 presents percent accuracy data during the sessions where training criteria 
were met for female rats. Statistically-significant differences were observed between 
strains in female rats F(2,17) = 4.330, p < 0.05, which was due to female BRAT rats 
exhibiting significantly poorer accuracy than LE and HZ rats. No statistically significant 
effects were found between LE and HZ rats.  
Figure 9 presents percent accuracy data during the sessions where training criteria 
were met for male and female rats. No statistically-significant differences were observed 






Figure 7 shows the percent accuracy as a function of strain (LE, HZ, or 
BRAT) in the male rats.  
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Figure 8 shows the percent accuracy as a function of strain (LE, 
HZ, or BRAT) in the female rats, *p < 0.05 versus LE, +p < 0.05 
versus HZ. 
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Figure 9 shows the percent accuracy as a function of strain (LE, 
HZ, or BRAT) in male and female rats. 
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Figure 10 presents the mean number of premature responses exhibited during the 
sessions where training criteria were met for male rats. No statistically-significant 
differences were observed between strains in male rats F(2,18) = 1.986, p > 0.05. 
Figure 11 presents the mean number of premature responses exhibited during the 
sessions where training criteria were met for female rats. No statistically-significant 
differences were observed between strains in female rats F(2,17) = 3.051, p > 0.05.  
Figure 12 presents the mean number of premature responses exhibited during the 
sessions where training criteria were met for male and female rats. Statistically-
significant differences were observed between strains F(2,38) = 4.865, p < 0.05, which 
was due to BRAT rats exhibiting more premature responses than LE and HZ rats. No 






Figure 10 shows premature responses as a function of strain (LE, HZ, or 
BRAT) in male rats. 
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Figure 11 shows premature responses as a function of strain (LE, 
HZ, or BRAT) in female rats. 
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Figure 12 shows premature responses as a function of strain (LE, 
HZ, or BRAT) in male and female rats, *p < 0.05 versus LE, ++p 







Figure 13 presents the mean number of omissions exhibited during the sessions 
where training criteria were met for male rats. No statistically-significant differences 
were observed between strains in male rats F(2,18) = 0.4552, p > 0.05. 
Figure 14 presents the mean number of omissions exhibited during the sessions 
where training criteria were met for female rats. No statistically-significant differences 
were observed between strains in female rats F(2,17) = 0.5753, p > 0.05. 
Figure 15 presents the mean number of omissions exhibited during the sessions 
where training criteria were met for male and female rats. No statistically-significant 






Figure 13 shows omissions as a function of strain (LE, HZ, or 
BRAT) in male rats.  
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Figure 14 shows omissions as a function of strain (LE, HZ, or BRAT) 
 in female rats.  
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Figure 15 shows omissions as a function of strain (LE, HZ, or BRAT) 
 in male and female rats.  
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Bodyweight and water intake 
 
After completing these experiments, all rats were returned to free-feeding and 
assessments of bodyweights and amount of 24 hour home-cage water consumption were 
conducted.  
Figure 16 presents the mean weights of the male rats. Statistically-significant 
effects were found in the male rats F(2,26) = 28.3, p < 0.0001, which were due to male 
HZ weighing more than LE and BRAT rats, and LE weighing more than BRAT rats. No 
statistically significant differences were found between LE and HZ rats. 
Figure 17 presents the mean weights of the female rats. Statistically-significant 
effects were found in the female rats F(2,25) = 16.07, p < 0.0001, which were due to 
female HZ weighing more than LE and BRAT rats, and LE weighing more than BRAT 






Figure 16 shows the mean weights as a function of strain (LE, HZ, 
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  Figure 17 shows the mean weights as a function of strain  
   (LE, HZ, or BRAT) in female rats, **p < 0.01 versus LE,   
   ++++p < 0.0001 versus HZ. 
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Figure 18 presents the 24 hour water consumption in male rats. Statistically-
significant effects were found in water consumption amounts in male rats F(2,26) = 180, 
p < 0.0001, which were due to the BRAT rats drinking more water than LE and HZ rats. 
No statistically significant differences were found between LE and HZ rats. 
Figure 19 presents the 24 hour water consumption in female rats. Statistically-
significant effects were found in water consumption amounts in female rats F(2,25) = 
295.7, p < 0.0001, which were due to BRAT rats drinking more water than LE and HZ 






Figure 18 shows the 24 hour water consumption as a function of 
 strain (LE, HZ, or BRAT) in male rats, ****p < 0.0001  versus 
 LE, ++++p < 0.0001 versus HZ.  
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Figure 19 shows the 24 hour water consumption as a function of 
 strain (LE, HZ, or BRAT) in female rats, ****p < 0.0001  versus 
 LE, ++++p < 0.0001 versus HZ. 
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Figure 20 presents the amount of water male rats consumed during a 60 minute 
session. Statistically-significant differences in water consumption were found among the 
male rats F(2,26) = 7.862, p < 0.01, which were due to male BRAT rats consuming more 
water than LE and HZ. No statistically significant differences were found between LE 
and HZ rats. 
Figure 21 presents the amount of water female rats consumed during a 60 minute 
session. Statistically-significant differences in water consumption were found among the 
female rats F(2,25) = 15.73, p < 0.0001, which were due to female BRAT rats consuming 
more water than LE and HZ. No statistically significant differences were found between 






  Figure 20 shows the amount of water consumed during a 60  
   minute session as a function of strain (LE, HZ, or BRAT) in  
   male rats, **p < 0.01 versus BRAT. 
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Figure 21 shows the amount of water consumed during a 60 minute 
 session as a function of strain (LE, HZ, or BRAT) in female rats, p**** 
 < 0.0001 versus BRAT. 
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Figure 22 presents the number of licks made during a 60 minute session in male 
rats. Two rats were excluded in this measure due to mechanical error with the lickometer 
equipment. Statistically-significant effects were found in the number of licks made in the 
male rats F(2,24) = 10.13, p < 0.001, which was due to male BRAT rats exhibiting more 
licks than LE and HZ. No statistically significant differences were found between LE and 
HZ rats. 
Figure 23 presents the number of licks made during a 60 minute session in female 
rats. Statistically significant effects were found in the number of licks made in the female 
rats F(2,25) = 38.32, p < 0.0001., which was due to female BRAT rats exhibiting more 







Figure 22 shows the number of licks made during a 60 minute 
 session as a function of strain (LE, HZ, or BRAT) in male rats, 
 **p < 0.01 versus BRAT. 
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  Figure 23 shows the number of licks made during a 60 minute  
   session as function of strain (LE, HZ, or BRAT) in female   
   rats, ****p < 0.0001 versus BRAT.  
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The present study provides the first report on the assessment of both male and 
female BRAT rats using the 5-CSRTT.  Male BRAT rats required significantly more 
trials to complete this task than LE rats (16.8% higher), while differences were not 
observed between strains for the female rats.  During the sessions that rats met the 
training criteria, only female BRAT rats displayed a lower percent accuracy (51.8%) than 
the HZ (61.1%) and LE rats (63.5%).  When males and females were combined, the 
BRAT rats required significantly more sessions to complete training than both the LE and 
HZ rats. Differences also were not found between strains in either male or female rats for 
omissions or the number of premature responses.  However, when increasing the sample 
sizes by combining both male and female rats, a significant increase in premature 
responses was observed in the BRAT rats compared to LE and HZ rats. The HZ rats were 
found to have heavier free-feeding weights than LE and BRAT rats, while BRAT rats 
weighed less than LE and HZ rats—similar to findings reported elsewhere (e.g., Arimura, 
Sawano, Redding, & Schally, 1968).  VP deficiency led to significantly greater home 
cage and experimental water consumption in BRAT rats compared to LE and HZ rats, 
while VP deficiency in HZ rats may not have been substantial enough to significantly 
enhance water consumption compared to LE rats. Furthermore, the BRAT rats made 




The training criteria used for the present study were developed in order to 
determine a steady state for attention accuracy for the purpose of making comparisons 
between different strains.  These criteria differ from other 5-CSRTT studies, which 
usually set training criteria toward attaining some a priori level of accuracy, such as 80% 
(e.g., Auclair, Besnard, Newman-Tancredi, & Depoortere, 2009; Agnoli & Carli, 2012).  
From the approach used here, many rats, including the LE rats, failed to achieve greater 
than 60% choice accuracy, and most were below 80% choice accuracy.  Moreover, some 
rats were removed from the study due to either failing to pass early phases of training or 
to exhibiting too much variability for day to day performance.  These criteria suggest that 
for studies aiming for a high accuracy, rats may initially reach a steady state of lower 
accuracy, such as the 60% value found in the present study, prior to gradually meeting a 
higher level of accuracy.  
In the present study, differences in attention were found in female BRAT rats but 
not in male BRATs. This is the first study to indicate a potential cognitive deficit in 
attention in female BRAT rats. Perhaps the present finding of impaired attention accuracy 
in the female BRAT rats can be attributed to the effects of hormonal cyclicity; the present 
study did not control for the rhythmic release of hormonal factors in the female strains. 
Additionally, it has been observed that the BRAT strain exhibits several alterations in a 
number of hormonal factors (Sokol and Zimmerman, 1982), and it is thus possible that 
these factors may be further disrupted in female versus male BRAT rats. Clearly, more 
research is needed to assess how sex differences may interact with VP to account for 
potential behavioral or cognitive effects. Moreover, aside from a previous assessment of 




studies have been conducted between strains in female BRAT rats, and therefore it is 
difficult to suggest what type of unique behavioral or cognitive profile may exist for 
female rats with VP deficiency. 
The closest comparisons between the present findings and previous studies are 
those conducted by Jentsch, Arguello, and Anzivino (2003) and Jentsch (2003), which 
both used a lateralized reaction time task (see introduction). In the study by Jentsch 
(2003), male HZ rats failed to exhibit differences in choice accuracy at 30, 5, and 2.5 sec 
durations but displayed improved choice accuracy at a 1 sec duration. In an another 
lateralized reaction time study, Jentsch, Arguello, and Anzivino (2003) reported that 
BRAT rats showed improved choice accuracy at 2.0 sec duration but displayed impaired 
choice accuracy at a 0.2 sec duration (Jenstch, Arguello, & Anzivino, 2003).  Considering 
these findings together, Jentsch, Arguello, and Anzivino (2003) suggested that increases 
in VPergic tone may diminish attention accuracy.  However, the present findings fail to 
support these conclusions, since accuracy changes were not observed in male BRAT or 
HZ rats, and that deficits, rather than improvements, in attention accuracy were observed 
in female BRAT rats.   
These differences may, in part, owe to the approaches used to assess attention.  
The present study employed a 5-CSRTT, which utilizes five receptacles that must be 
surveyed by an animal in order to attend to a 0.5 second pulse of light; whereas the 
lateralized reaction time task includes only two choices, which are located adjacent to a 
central receptacle that an animal uses to begin each trial.  Thus, the 5-CSRTT may 




to be empirically studied. Certainly, the present findings are more in line with previous 
investigations (see below) suggesting that VP deficiency impairs cognitive performance. 
 As mentioned previously, the BRAT rats made significantly more premature 
responses than the LE and HZ rats. In the 5-CSRTT premature responding is generally 
considered a measure of impulsivity (e.g., Robbins, 2002; Chudasama & Robbins, 2004; 
Amitai & Markou, 2010). For example, psychostimulants such as methylphenidate tend 
to dose-dependently increase premature responding (e.g. Paterson, Ricciardi, Wetzler, & 
Hanania, 2011; Navarra, et al. 2008), which may relate to enhanced locomotor activity at 
similar doses.  Given this general interpretation for premature responding in the 5-
CSRTT, the present findings may indicate greater impulsivity in BRAT rats.  BRAT rats 
have also been shown to exhibit increased locomotor activity compared to LE controls 
(e.g.,Cilia, et al. 2010; Schank, 2009) and have lower increases in locomotor activity 
following d-amphetamine administration than LE controls (Cilia et al., 2010).  The 
increases in impulsivity found in the present study and increased locomotor activity 
found in other studies might be caused by differences in the dopamine system of BRAT 
rats (e.g., see Dawson Jr., Wallace, & King, 1990; Feenstra, Snijdewint, Galen, & Boer, 
1990; and Shilling et al., 2006, for altered neurotransmitter levels found in BRATs).  In 
particular, Shilling et al. (2006) reported that BRAT rats displayed an upregulation of 
dopamine D2 receptors in the nucleus accumbens shell and dorsomedial caudate/putamen 
compared to LE rats.  
 As noted above, the 5-CSRTT has been suggested to involve various subtypes of 




Robbins, 2002). Much progress has been made delineating the substrates and functional 
neurochemistry between these subtypes of attention. For example, a study by McGaughy, 
Kaiser, and Sarter (1998) demonstrated a direct relationship of reduced 
acheylcholinesterase-fiber density and disrupted performance in a rat model of sustained 
attention— suggesting that cholinergic transmission is necessary for this particular 
subtype of attention. Moreover, perhaps one of the more intuitive mechanisms to occur 
before attention processes can begin is arousal. Among the many brain structures 
involved in arousal, the brain stem is particularly important for initiating this process 
(e.g., see Jones, 2003).  As such, two substructures of the brain stem, the medulla and 
locus coeruleus, have been largely implicated in arousal and have been shown to involve 
neurotransmitters such as glutamate and noradrenaline (e.g., Jones, 2003; Sara, 2009). 
The BRAT strain has been shown to have developmental impairments within the medulla 
measured in neonatal BRAT rat pups (Boer, Van Rheenen-Verberg, & Uylings, 1982), 
and elevations in noradrenergic concentrations were also found in the strain (Dawson Jr., 
Wallace, & King, 1990).  Although further research is necessary to evaluate these agents 
within the process of arousal, and particularly across sexes within the BRAT strain, we 
the investigators suspect that perturbations within these arousal mechanisms may also be 
related to the lower accuracy effect found in the present study.  
  Few other studies have evaluated cognitive differences in the BRAT strain—
several of which have been briefly presented in the introduction of this document. As 
previously mentioned in the introduction of this document, impaired performance in 
shock-motivated memory paradigms have been suggested in the BRAT strain of rats (De 




BRAT rats also display an innate deficit in the pre-pulse inhibition response, which 
appears to measure sensory gating; a process implicated in early attention processing 
(e.g., Braff, Swerdlow, & Geyer, 1999).  Moreover, current research has directly linked 
polymorphisms within the AVPR1a promoter region of the VP gene to altered pre-pulse 
inhibition responses (Levin et al., 2009). This involvement of VP in pre-pulse measures 
may be  partially responsible for the pre-pulse inhibition deficits found in both male (e.g., 
Feifel & Priebe, 2001; Cilia et al., 2010; Feifel, Melendez, & Shilling, 2004) and female 
(Feifel, Shilling, & Melendez, 2010) BRATs; though, more research is necessary 
exploring this area. Nonetheless, such deficits in pre-pulse inhibition may compromise 
performance of BRATs in attention procedures, possibly resulting in a poorer ability to 
shift attention between stimuli. The findings, taken with those from the present study, 
suggest that diminished VP concentrations contribute to declines in attention, and 
potentially other domains of cognition.  
In addition to exploring the role vasopressin may play in behavioral and cognitive 
processes, VP deficiency has been recently explored as a screening model for 
antipsychotic drugs.  Both antipsychotic drugs (e.g., Cilia et al., 2010; Feifel & Priebe, 
2001) and the putative antipsychotic drug and neurotensin NT1 receptor agonist 
PD149163 (Feifel, Melendez, & Shilling, 2004) have been shown to attenuate pre-pulse 
inhibition deficits in BRAT rats.  Further, PD149163 and the antipsychotic drug 
clozapine have both reversed social discrimination deficits displayed in BRAT rats 
(Feifel et al., 2009).  In addition to these behavioral data, subchronic administration of the 
NMDA noncompetitive receptor antagonist and psychotomimetic phencyclidine has been 




deficits in social interaction (Tanaka et al., 2003).  Further, as noted earlier, Shilling et al. 
(2006) reported an upregulation of D2 receptors, possibly suggestive of enhanced 
dopaminergic signaling.  Taken together, BRAT rats may have utility for antipsychotic 
drug development. 
Taking together these pre-pulse inhibition findings and social deficits observed in 
the BRAT strain, researchers have suggested that the strain may be a useful animal model 
of schizophrenia due to the behavioral responses following both established and novel 
antipsychotic drug administration (e.g., Feifel, 2010; Cilia et al., 2010; Feifel et al., 
2009). Other research has also included VP as a potential biochemical candidate involved 
in austism spectrum disorder (e.g., see Carter, 2007; and, Lukas & Neumann, 2012 for 
review on the subject). As such, the BRATs have also been suggested to perhaps 
subserve a role in this area of research (e.g., Insel, O’Brien, & Leckman, 1999; Schank, 
2009); however, further investigation is necessary which expands upon this possibility.   
The present study adds to previous research investigating the behavioral-cognitive 
profile of the BRAT rat, indicating that VP deficiency may diminish attention in female, 
but perhaps not male, BRAT rats.  More research is necessary which further evaluates the 
other perturbed factors in the BRAT strain (e.g., hormones, monoamines, etc.), and 
moreover, how these alterations can affect performance in behavioral and cognitive tasks. 
Additionally, the present findings and earlier investigations suggest that BRAT rats could 
be used for the screening of antipsychotic drugs; particularly in models sensitive to 




the behavioral and cognitive profile of VP deficiency and to elucidate the 
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Choice Lights OFF 
Houselight ON 











Choice Lights OFF 
Houselight ON 
L DEAC (5.0s) 
 
CR?  YES 
ICR/NNP 




LP = Lever Press  
NP = Nose Poke 
T = Time Interval 
LH = Limited Hold Period 
CR = Correct Response 
ICR = Incorrect Response 
NNP = No Nose Poke 


























^HOUSELIGHT = 15 
^POKE1 = 4 
^POKE2 = 5 
^POKE3 = 6 
^POKE4 = 7 
^POKE5 = 8 
^FAN = 16 




  1":ON ^FAN--->S2 
S2, 
  #START: ON ^HOUSELIGHT, ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5--->S3 
S3, 
  #R^POKE1:ADD A; OFF ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5; ON ^PELLET; SHOW 1, 
POKE1, A--->S4 
  #R^POKE2:ADD B; OFF ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5; ON ^PELLET; SHOW 2, 
POKE2, B--->S4 
  #R^POKE3:ADD C; OFF ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5; ON ^PELLET; SHOW 3, 
POKE3, C--->S4 
  #R^POKE4:ADD D; OFF ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5; ON ^PELLET; SHOW 4, 
POKE4, D--->S4 
  #R^POKE5:ADD E; OFF ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5; ON ^PELLET; SHOW 5, 
POKE5, E--->S4 
S4, 
  0.1":OFF ^PELLET; ADD F;SHOW 6, PELLET, F--->S5 
S5, 
  5":ON ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5--->S3 
 
S.S.2, 
  S1, 
   #START:--->S2 
  S2, 
   60":ON ^PELLET;ADD F;SHOW 6, PELLET, F--->S3 
  S3, 
   0.1":OFF ^PELLET--->S2  
 
S.S.3, 














^HOUSELIGHT = 15 
^POKE1 = 4 
^POKE2 = 5 
^POKE3 = 6 
^POKE4 = 7 
^POKE5 = 8 
^FAN = 16 





  1":ON ^FAN--->S2 
S2, 
  #START: ON ^HOUSELIGHT, ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5--->S3 
S3, 
  #R^POKE1:ADD A; OFF ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5; ON ^PELLET; SHOW 1, 
POKE1, A--->S4 
  #R^POKE2:ADD B; OFF ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5; ON ^PELLET; SHOW 2, 
POKE2, B--->S4 
  #R^POKE3:ADD C; OFF ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5; ON ^PELLET; SHOW 3, 
POKE3, C--->S4 
  #R^POKE4:ADD D; OFF ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5; ON ^PELLET; SHOW 4, 
POKE4, D--->S4 
  #R^POKE5:ADD E; OFF ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5; ON ^PELLET; SHOW 5, 
POKE5, E--->S4 
S4, 
  0.1":OFF ^PELLET; ADD F;SHOW 6, PELLET, F--->S5 
S5, 
  5":ON ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5--->S3 
 
S.S.2, 
  S1, 














^HOUSELIGHT = 15 
^POKE1 = 4 
^POKE2 = 5 
^POKE3 = 6 
^POKE4 = 7 
^POKE5 = 8 
^FAN = 16 
^PELLET = 9 





  1":ON ^FAN--->S2 
S2, 
  #START: ON ^HOUSELIGHT,^CENTERLEVER--->S3 
S3, 
  #R^CENTERLEVER:ON ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5--->S4 
S4, 
  #R^POKE1:ADD A; OFF ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5; ON ^PELLET; 
SHOW 1, POKE1, A--->S5 
  #R^POKE2:ADD B; OFF ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5; ON ^PELLET; 
SHOW 2, POKE2, B--->S5 
  #R^POKE3:ADD C; OFF ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5; ON ^PELLET; 
SHOW 3, POKE3, C--->S5 
  #R^POKE4:ADD D; OFF ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5; ON ^PELLET; 
SHOW 4, POKE4, D--->S5 
  #R^POKE5:ADD E; OFF ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5; ON ^PELLET; 
SHOW 5, POKE5, E--->S5 
S5, 




  S1, 











\Five choice serial reaction time task 
 
\Written by Adam Prus and Mike Berquist 
 
\January 18 2012 
 
\0.5 sec light pulse in recepticle.  Nosepoke leads to food pellet. 
 
\Session last 80 trials or 30 minutes 
\incorrect or omission leads to 5 sec time out 
 
\ Training steps = 1.  FT60 2.  Nosepoke = food pellet delivery (all receptacles lighted)  3.  Only 
light hole triggers pellet (stays lit until response - incorrect leads to timeout)  
 
\4.  Lever press triggers light (light stays on) 5.  Lever press triggers light (light stays on for 
maybe 5 sec  6.  Same but reduce light duration until 0.5" responding occurs 







^Poke1 = 4 
^Poke2 = 5 
^Poke3 = 6  
^Poke4 = 7 
^Poke5 = 8 
^Houselight = 15 
^CenterLever = 2 
^Pellet = 9 















\H=FOR NO RESPONSE CALCULATION 
\Y=CHOOSES LIGHT 
\Z=LIST FOR RANDOM LIGHT 
 
LIST Z = 4,5,6,7,8 




\SHOW 1 = TIME 
\SHOW 2 = NUMBER OF TRIALS 
\SHOW 3 = OMISSIONS 
\SHOW 4 = PREMATURE 
\SHOW 5 =  
\SHOW 6 = %CORRECT 







     
  1":  ON ^FAN--->S2 
 
S2, 
     
  #START: ON ^HOUSELIGHT,^CENTERLEVER--->S3 
 
S3, 
  #R2:ADD D--->S4 
S4,  
  0.1":RANDI Y = Z; SET B(1)=Y;SHOW 2, TRIALS, D; IF B(1)=4 [@FOUR,@OTHER] 
          
      @FOUR:SET B(2)=5, B(3)=6, B(4)=7, B(5)=8--->S5 
          
      @OTHER:IF B(1)=5 [@FIVE,@OTHER] 
                
            @FIVE:SET B(2)=4,B(3)=6,B(4)=7,B(5)=8--->S5 
                
            @OTHER:IF B(1)=6 [@SIX,@OTHER] 
                      
                 @SIX:SET B(2)=4,B(3)=5,B(4)=7,B(5)=8--->S5 
                      
                 @OTHER:IF B(1)=7 [@SEVEN,@EIGHT] 
                           
                         @SEVEN:SET B(2)=4,B(3)=5,B(4)=6,B(5)=8--->S5 
                           





  5":ON Y--->S6 \PREMATURE RESPONSE GOES HERE 
S6, 
  #RB(1):ADD E;ON ^PELLET;OFF Y;SHOW 6,CORRECT,E--->S7 \SET G=E+F;SHOW 6, 
%CORRECT, (E/G*100);SHOW 7,TOT_RESP,G 
  #RB(2)!#RB(3)!#RB(4)!#RB(5):OFF Y; ADD F--->S8 \INCORRECT,TIMEOUT ;SET 
G=E+FSHOW 6, %CORRECT, (E/G*100);SHOW 7,TOT_RESP,G 
  5":OFF Y;ADD C;SHOW 3, OMISSIONS, C--->S8 
S7,     
  0.1":OFF ^PELLET--->S3 
S8, \TIMEOUT1 
  0.1":OFF ^HOUSELIGHT--->S9 
S9, \TIMEOUT2 









     
  #START:--->S2 
 
S2, 
     
  1":ADD T;Show 1, Timer, T; IF D>100 [@END,@CONT] 
              
            @END:SET D=100;IF G=0 [@NORESPONSE,@RESPONSE] 
                   @NORESPONSE:SET H = 999;SHOW 1, TIMER, T; SHOW 2, TRIALS, D; 
SHOW 3, OMISSIONS, C;SHOW 4, PREMATURE, A; SHOW 6, CORRECT, E;SHOW 
7,TOT_RESP,G--->STOPABORTFLUSH 
 
                   @RESPONSE:SHOW 1, TIMEr, T; SHOW 2, TRIALS, D; SHOW 3, OMISSIONS, 
C;SHOW 4, PREMATURE, A; SHOW 6, CORRECT, e--->STOPABORTFLUSH              
            @CONT:  IF T>=1800 [@END,@CONT] 
                           
                   @END:SHOW 1, TIMER, T; SHOW 2, TRIALS, D; SHOW 3, OMISSIONS, 
C;SHOW 4, PREMATURE, A; SHOW 6, CORRECT, e--->STOPABORTFLUSH 
                            












\Five choice serial reaction time task 
 
\Written by Adam Prus and Mike Berquist 
 
\January 18 2012 
 
\0.5 sec light pulse in recepticle.  Nosepoke leads to food pellet. 
 
\Session last 80 trials or 30 minutes 
\incorrect or omission leads to 5 sec time out 
 
\ Training steps = 1.  FT60 2.  Nosepoke = food pellet delivery (all receptacles lighted)  3.  Only 
light hole triggers pellet (stays lit until response - incorrect leads to timeout)  
 
\4.  Lever press triggers light (light stays on) 5.  Lever press triggers light (light stays on for 
maybe 5 sec  6.  Same but reduce light duration until 0.5" responding occurs 







^Poke1 = 4 
^Poke2 = 5 
^Poke3 = 6  
^Poke4 = 7 
^Poke5 = 8 
^Houselight = 15 
^CenterLever = 2 
^Pellet = 9 















\H=FOR NO RESPONSE CALCULATION 
\Y=CHOOSES LIGHT 
\Z=LIST FOR RANDOM LIGHT 
 
LIST Z = 4,5,6,7,8 




\SHOW 1 = TIME 
\SHOW 2 = NUMBER OF TRIALS 
\SHOW 3 = OMISSIONS 
\SHOW 4 = PREMATURE 
\SHOW 5 =  
\SHOW 6 = %CORRECT 







     
  1":  ON ^FAN--->S2 
 
S2, 
     
  #START: ON ^HOUSELIGHT,^CENTERLEVER--->S3 
 
S3, 
  #R2:ADD D--->S4 
S4,  
  0.1":RANDI Y = Z; SET B(1)=Y;SHOW 2, TRIALS, D; IF B(1)=4 [@FOUR,@OTHER] 
          
      @FOUR:SET B(2)=5, B(3)=6, B(4)=7, B(5)=8--->S5 
          
      @OTHER:IF B(1)=5 [@FIVE,@OTHER] 
                
            @FIVE:SET B(2)=4,B(3)=6,B(4)=7,B(5)=8--->S5 
                
            @OTHER:IF B(1)=6 [@SIX,@OTHER] 
                      
                 @SIX:SET B(2)=4,B(3)=5,B(4)=7,B(5)=8--->S5 
                      
                 @OTHER:IF B(1)=7 [@SEVEN,@EIGHT] 
                           
                         @SEVEN:SET B(2)=4,B(3)=5,B(4)=6,B(5)=8--->S5 
                           





  5":ON Y--->S6 \PREMATURE RESPONSE GOES HERE 
  #RB(1)!#RB(2)!#RB(3)!#RB(4)!#RB(5):ADD A;SHOW 4, PREMATURE, A--->S8 
S6, 
  #RB(1):ADD E;ON ^PELLET;OFF Y;SHOW 6,CORRECT,E--->S7 \SET G=E+F;SHOW 6, 
CORRECT, E;SHOW 7,TOT_RESP,G 
  #RB(2)!#RB(3)!#RB(4)!#RB(5):OFF Y; ADD F--->S8 \INCORRECT,TIMEOUT ;SET 
G=E+F;SHOW 6, CORRECT, E;SHOW 7,TOT_RESP,G 
  5":OFF Y;ADD C;SHOW 3, OMISSIONS, C--->S8 
S7,     
  0.1":OFF ^PELLET--->S3 
S8, \TIMEOUT1 
  0.1":OFF ^HOUSELIGHT--->S9 
S9, \TIMEOUT2 









     
  #START:--->S2 
 
S2, 
     
  1":ADD T;Show 1, Timer, T; IF D>100 [@END,@CONT] 
              
            @END:SET D=100;IF G=0 [@NORESPONSE,@RESPONSE] 
                   @NORESPONSE:SET H = 999;SHOW 1, TIMER, T; SHOW 2, TRIALS, D; 
SHOW 3, OMISSIONS, C;SHOW 4, PREMATURE, A; SHOW 6, CORRECT, E;SHOW 
7,TOT_RESP,G--->STOPABORTFLUSH 
 
                   @RESPONSE:SHOW 1, TIMEr, T; SHOW 2, TRIALS, D; SHOW 3, OMISSIONS, 
C;SHOW 4, PREMATURE, A; SHOW 6, CORRECT, E--->STOPABORTFLUSH              
            @CONT:  IF T>=1800 [@END,@CONT] 
                           
                   @END:SHOW 1, TIMER, T; SHOW 2, TRIALS, D; SHOW 3, OMISSIONS, 
C;SHOW 4, PREMATURE, A; SHOW 6, CORRECT, E--->STOPABORTFLUSH 
                            










\Five choice serial reaction time task 
 
\Written by Adam Prus and Mike Berquist 
 
\April 4 2012 
 
\0.5 sec light pulse in recepticle.  Nosepoke leads to food pellet. 
 
\Session last 80 trials or 30 minutes 
\incorrect or omission leads to 5 sec time out 
 
\ Training steps = 1.  FT60 2.  Nosepoke = food pellet delivery (all receptacles lighted)  3.  Only 
light hole triggers pellet (stays lit until response - incorrect leads to timeout)  
 
\4.  Lever press triggers light (light stays on) 5.  Lever press triggers light (light stays on for 
maybe 5 sec  6.  Same but reduce light duration until 0.5" responding occurs 







^Poke1 = 4 
^Poke2 = 5 
^Poke3 = 6  
^Poke4 = 7 
^Poke5 = 8 
^Houselight = 15 
^CenterLever = 2 
^Pellet = 9 





























LIST Z = 4,5,6,7,8 
DIM B = 6 
DIM I = 100 
DIM J = 100 
DIM K = 100 
DIM L = 100 
DIM M = 100 




\SHOW 1 = TIME 
\SHOW 2 = NUMBER OF TRIALS 
\SHOW 3 = OMISSIONS 
\SHOW 4 = PREMATURE 
\SHOW 5 = INCORRECT 
\SHOW 6 = CORRECT 







     
  1":  ON ^FAN--->S2 
 
S2, 
     
  #START: ON ^HOUSELIGHT,^CENTERLEVER;SET D=0--->S3 
 
S3, 
  #R2:ADD D--->S4 
S4,  
  0.1":RANDI Y = Z; SET B(1)=Y;SHOW 2, TRIALS, D;Z1; IF B(1)=4 [@FOUR,@OTHER]        




      @OTHER:IF B(1)=5 [@FIVE,@OTHER] 
            @FIVE:SET B(2)=4,B(3)=6,B(4)=7,B(5)=8, L(D)=2--->S5 \tag 
            @OTHER:IF B(1)=6 [@SIX,@OTHER] 
                 @SIX:SET B(2)=4,B(3)=5,B(4)=7,B(5)=8, L(D)=3--->S5 \tag 
                 @OTHER:IF B(1)=7 [@SEVEN,@EIGHT] 
                         @SEVEN:SET B(2)=4,B(3)=5,B(4)=6,B(5)=8, L(D)=4--->S5 \tag 
                         @EIGHT:SET B(2)=4,B(3)=5,B(4)=6,B(5)=7, L(D)=5--->S5 \tag 
S5, 
  5":ON Y--->S6 \PREMATURE RESPONSE GOES HERE 
  #RB(1)!#RB(2)!#RB(3)!#RB(4)!#RB(5):ADD A;SHOW 4, PREMATURE, A--->S9 
S6, 
  #RB(1):ADD E;ON ^PELLET;OFF Y;SHOW 6,CORRECT,E;Z2--->S8 \SET G=E+F;SHOW 
6, CORRECT, E;SHOW 7,TOT_RESP,G 
  #RB(2)!#RB(3)!#RB(4)!#RB(5):OFF Y; ADD F;SHOW 5,INCORRECT,F;Z2--->S9 
\INCORRECT,TIMEOUT ;SET G=E+F;SHOW 6, CORRECT, E;SHOW 7,TOT_RESP,G 
  0.5":OFF Y;Z2--->S7 
S7, 
  #RB(1):ADD E;ON ^PELLET;OFF Y;SHOW 6,CORRECT,E--->S8 \SET G=E+F;SHOW 6, 
CORRECT, E;SHOW 7,TOT_RESP,G 
  #RB(2)!#RB(3)!#RB(4)!#RB(5):OFF Y; ADD F;SHOW 5,INCORRECT,F--->S9 
\INCORRECT,TIMEOUT ;SET G=E+F;SHOW 6, CORRECT, E;SHOW 7,TOT_RESP,G 
  5":OFF Y;ADD C;SHOW 3, OMISSIONS, C--->S9 
S8,     
  0.1":OFF ^PELLET;Z3--->S3 
S9, \TIMEOUT1 
  0.1":OFF ^HOUSELIGHT;Z3--->S10 
S10, \TIMEOUT2 






S.S.2, \ENDS AFTER 30 MIN OR 100 TRIALS 
 
S1, 
     
  #START:--->S2 
 
S2, 
     
  1":ADD T;Show 1, Timer, T; IF D>100 [@END,@CONT] 
            @END:SET D=100;IF G=0 [@NORESPONSE,@RESPONSE] 
                   @NORESPONSE:SET H = 999;SHOW 1, TIMER, T; SHOW 2, TRIALS, D; 
SHOW 3, OMISSIONS, C;SHOW 4, PREMATURE, A;SHOW 5, INCORRECT, F;SHOW 6, 
CORRECT, E;SHOW 7,TOT_RESP,G--->STOPABORTFLUSH 
                   @RESPONSE:SHOW 1, TIMER, T; SHOW 2, TRIALS, D; SHOW 3, OMISSIONS, 
C;SHOW 4, PREMATURE, A;SHOW 5,INCORRECT,F; SHOW 6, CORRECT, E---




            @CONT:  IF T>=1800 [@END,@CONT]              
                   @END:SHOW 1, TIMER, T; SHOW 2, TRIALS, D; SHOW 3, OMISSIONS, 
C;SHOW 4, PREMATURE, A; SHOW 6, CORRECT, E--->STOPABORTFLUSH           
                   @CONT:--->S2 
\----------------------------------------------------------------------------------- 
S.S.3, \DV PER TRIAL 
S1, 
   #Z1:SET I(D)=Y--->S2 \SIGNAL POSITION 
S2, 
   #Z2:SET J(D)=1--->S3 \ONLY GATHERS PREMATURES 
   #R4:SET K(D)=4--->S1 
   #R5:SET K(D)=5--->S1 
   #R6:SET K(D)=6--->S1 
   #R7:SET K(D)=7--->S1 
   #R8:SET K(D)=8--->S1 
S3, 
   #Z3:SET M(D)=1--->S1 \ONLY GATHERS RESPONSES AFTER SIGNAL 
   #R4:SET N(D)=4--->S1 
   #R5:SET N(D)=5--->S1 
   #R6:SET N(D)=6--->S1 
   #R7:SET N(D)=7--->S1 
   #R8:SET N(D)=8--->S1 
